Abstract
Management of fecal incontinence (FI) should be based on a meticulous assessment of pathophysiology through both clinical and physiological diagnostic workup. There are cases with prevalently altered diet and hygiene. Very frequently, diarrhea and constipation can be found involved in the development and maintenance of FI [1-3], both in the presence or absence of other traumatic or nontraumatic causes. Consequently, in those cases, treatment must be directed toward cure of these dysfunctions, either as single-line or combined treatment. Little evidence exists in the available literature about medical therapy for FI; recently, a Cochrane Database Review high-lighted that “there is little evidence with which to assess the use of drug therapies for the management of fecal incontinence” [4]. Therefore, medical treatment in FI is debatable and often pragmatic.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Nelson R, Furner S, Jesudason V (1998) Fecal incontinence in Wisconsin nursing homes: prevalence and associations. Dis Colon Rectum 41:1226–1229
Chassagne P, Landrin I, Neveu C et al (1999) Fecal incontinence in the institutionalized elderly: incidence, risk factors, and prognosis. Am J Med 106:185–190
Levine MD (1975) Children with encopresis: A descriptive analysis. Pediatrics 56:412–416
Cheetham M, Brazzelli M, Norton C et al (2003) Drug treatment for fecal incontinence in adults. Cochrane Database Syst Rev 4:1–26
Goode PS, Burgio KL, Halli AD et al (2005) Prevalence and correlates of fecal incontinence in communitydwelling older adults. J Am Geriatr Soc 53:629–635
Drossman DA (1989) What can be done to control incontinence associated with irritable bowel syndrome? Am J Gastroenterol 84:365–366
Olden KW (2002) Diagnosis of irritable bowel syndrome. Gastroenterology 122:1701–1714
Lembo TJ, Fink RN (2002) Clinical assessment of irritable bowel syndrome. J Clin Gastroenterol 35:S31–S36
Fine KD, Meyer RL, Lee EL (1997) The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet Gastroenterology 112:1830–1838
Bliss DZ, Jung HJ, Savok K et al (2001) Supplementation with dietary fiber improves fecal incontinence. Nurs Res 50:203–213
Palmer KR, Corbett CL, Holdsworth CD (1980) Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology 79:1272–1275
Read MG, Read NM, Duthie HL (1979) Effect of loperamide in anal sphincter function in patients with diarrhea. Gut 20:A942
Bergman L, Djarv L (1981) A comparative study of loperamide and diphenoxylate in the treatment of chronic diarrhoea caused by intestinal resection. Ann Clin Res 13:402–405
Read M, Read NW, Barber DC et al (1982) Effects of loperamide on anal sphincter function in patients complaining of chronic diarrhea with fecal incontinence and urgency. Dig Dis Sci 27:807–814
Hallgren T, Fasth S, Delbro DS et al (1994) Loperamide improves anal sphincter function and continence after restorative proctocolectomy. Dig Dis Sci 39:2612–2618
Arnbjornsson E, Breland U, Kullendorff CM et al (1986) Effect of loperamide on faecal control after rectoplasty for high imperforate anus. Acta Chir Scand 152:215–216
Carapeti EA, Kamm MA, Evans BK et al (1999) Topical phenylephrine increases anal sphincter resting pressure. Br J Surg 86:267–270
Cheetham MJ, Kamm MA, Phillips RK (2001) Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut 48:356–359
Ritchie JA, Truelove SC (1980) Comparison of various treatments for irritable bowel syndrome. Br Med J 281:1317–1319
Farrar JT (1982) The effects of drugs on intestinal motility. Clin Gastroenterol 11:673–681
Santoro GA, Eitan BZ, Pryde A et al (2000) Open study of low-dose amitriptyline in the treatment of patients with idiopathic fecal incontinence. Dis Colon Rectum 43:1676–1681
Chassagne P, Jego A, Gloc P et al (2000) Does treatment of constipation improve faecal incontinence in institutionalized elderly patients? Age Ageing 29:159–164
Prather CM, Camilleri M, Zinsmeister AR et al (2000) Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 118:463–468
Tougas G, Snape WJ Jr, Otten MH et al (2002) Longterm safety of tegaserod in patients with constipationpredominant irritable bowel syndrome. Aliment Pharmacol Ther 16:1701–1708
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this chapter
Cite this chapter
Ratto, C., Parello, A., Donisi, L., Litta, F., Doglietto, G.B. (2007). Medical Treatment of Fecal Incontinence. In: Ratto, C., Doglietto, G.B., Lowry, A.C., Påhlman, L., Romano, G. (eds) Fecal Incontinence. Springer, Milano. https://doi.org/10.1007/978-88-470-0638-6_14
Download citation
DOI: https://doi.org/10.1007/978-88-470-0638-6_14
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0637-9
Online ISBN: 978-88-470-0638-6
eBook Packages: MedicineMedicine (R0)